Literature DB >> 15117455

Fine specificity and cross-clade reactivity of HIV type 1 Gag-specific CD4+ T cells.

Philip J Norris1, Howell F Moffett, Christian Brander, Todd M Allen, Kristin M O'Sullivan, Lisa A Cosimi, Daniel E Kaufmann, Bruce D Walker, Eric S Rosenberg.   

Abstract

Despite growing evidence that HIV-1-specific CD4(+) T helper (Th) cells may play a role in the control of viremia, discrete Th cell epitopes remain poorly defined. Furthermore, it is not known whether Th cell responses generated using vaccines based on clade B virus sequences will elicit immune responses that are effective in regions of the world where non-clade B viruses predominate. To address these issues we isolated CD4(+) T cell clones from individuals with vigorous HIV-1-specific Th cell responses and identified the minimum epitopes recognized. The minimum peptide length required for induction of CD4(+) T cell proliferation, IFN-gamma secretion, and cytolytic activity ranged from 9 to 16 amino acids in the five epitopes studied. Cross-clade recognition of the defined epitopes was examined for variant peptides from clades A, B, C, D, and AE. Over half the variant epitopes (17 of 32) exhibited impaired recognition, defined as less than 50% of the IFN-gamma secretion elicited by B clade consensus sequence. There was no evidence for antagonistic activity mediated by the variant peptides, and despite strong responses there was no escape of autologous virus from Th responses in the epitopes we studied. Abrogated recognition of variant CD4(+) T cell epitopes presents a potential obstacle to vaccine development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15117455      PMCID: PMC2553686          DOI: 10.1089/088922204322996554

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  59 in total

1.  HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus.

Authors:  Marcus Altfeld; Todd M Allen; Xu G Yu; Mary N Johnston; Deepak Agrawal; Bette T Korber; David C Montefiori; David H O'Connor; Ben T Davis; Paul K Lee; Erica L Maier; Jason Harlow; Philip J R Goulder; Christian Brander; Eric S Rosenberg; Bruce D Walker
Journal:  Nature       Date:  2002-11-28       Impact factor: 49.962

2.  Examination of the highly diverse CD4(+) T-cell repertoire directed against an influenza peptide: a step towards TCR proteomics.

Authors:  Thomas O Cameron; George B Cohen; Sabina A Islam; Lawrence J Stern
Journal:  Immunogenetics       Date:  2002-11-07       Impact factor: 2.846

3.  Characterization of a helper T cell epitope recognized by mice of a low responder major histocompatibility type.

Authors:  J E Kim; M Kojima; R Houghten; C D Pendleton; J L Cornette; C DeLisi; J A Berzofsky
Journal:  Mol Immunol       Date:  1990-10       Impact factor: 4.407

4.  T helper cell epitope of rabies virus nucleoprotein defined by tri- and tetrapeptides.

Authors:  H C Ertl; B Dietzschold; L Otvos
Journal:  Eur J Immunol       Date:  1991-01       Impact factor: 5.532

5.  Bi-specific monoclonal antibodies: selective binding and complement fixation to cells that express two different surface antigens.

Authors:  J T Wong; R B Colvin
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

6.  The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant.

Authors:  H Bhayani; F R Carbone; Y Paterson
Journal:  J Immunol       Date:  1988-07-15       Impact factor: 5.422

7.  Sequences outside a minimal immunodominant site exert negative effects on recognition by staphylococcal nuclease-specific T cell clones.

Authors:  M S Vacchio; J A Berzofsky; U Krzych; J A Smith; R J Hodes; A Finnegan
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

8.  Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion.

Authors:  R F Siliciano; T Lawton; C Knall; R W Karr; P Berman; T Gregory; E L Reinherz
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

9.  Evaluation of antigen-specific responses using in vitro enriched T cells.

Authors:  N Jones; D Agrawal; M Elrefaei; A Hanson; V Novitsky; J T Wong; Huyen Cao
Journal:  J Immunol Methods       Date:  2003-03-01       Impact factor: 2.303

10.  Diverse repertoire of HIV-1 p24-specific, IFN-gamma-producing CD4+ T cell clones following immune reconstitution on highly active antiretroviral therapy.

Authors:  Eli Boritz; Brent E Palmer; Brian Livingston; Alessandro Sette; Cara C Wilson
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

View more
  21 in total

1.  Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection.

Authors:  Ronald J Messer; Ulf Dittmer; Karin E Peterson; Kim J Hasenkrug
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-05       Impact factor: 11.205

2.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition.

Authors:  Zarixia Zavala-Ruiz; Iwona Strug; Bruce D Walker; Philip J Norris; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-26       Impact factor: 11.205

3.  HLA-restricted epitope identification and detection of functional T cell responses by using MHC-peptide and costimulatory microarrays.

Authors:  Jennifer D Stone; Walter E Demkowicz; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-23       Impact factor: 11.205

Review 4.  Advances in FIV vaccine technology.

Authors:  Elizabeth W Uhl; Marcus Martin; James K Coleman; Janet K Yamamoto
Journal:  Vet Immunol Immunopathol       Date:  2008-01-20       Impact factor: 2.046

5.  The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry.

Authors:  Jason G Williams; Kenneth B Tomer; Catarina E Hioe; Susan Zolla-Pazner; Philip J Norris
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-27       Impact factor: 3.109

6.  Protein kinase C theta regulates stability of the peripheral adhesion ring junction and contributes to the sensitivity of target cell lysis by CTL.

Authors:  Allison M Beal; Nadia Anikeeva; Rajat Varma; Thomas O Cameron; Philip J Norris; Michael L Dustin; Yuri Sykulev
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

7.  Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope.

Authors:  Philip J Norris; Jennifer D Stone; Nadezhda Anikeeva; John W Heitman; Ingrid C Wilson; Dale F Hirschkorn; Margaret J Clark; Howell F Moffett; Thomas O Cameron; Yuri Sykulev; Lawrence J Stern; Bruce D Walker
Journal:  Mol Immunol       Date:  2005-10-07       Impact factor: 4.407

8.  The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers.

Authors:  Juan P Giraldo-Vela; Richard Rudersdorf; Chungwon Chung; Ying Qi; Lyle T Wallace; Benjamin Bimber; Gretta J Borchardt; Debra L Fisk; Chrystal E Glidden; John T Loffredo; Shari M Piaskowski; Jessica R Furlott; Juan P Morales-Martinez; Nancy A Wilson; William M Rehrauer; Jeffrey D Lifson; Mary Carrington; David I Watkins
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

9.  Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells.

Authors:  Philip J Norris; Howell F Moffett; Otto O Yang; Daniel E Kaufmann; Margaret J Clark; Marylyn M Addo; Eric S Rosenberg
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and Germany.

Authors:  Thomas Böhler; Vanessa Mrosek; Kerstin Müller; Paul Schnitzler; Martin Hartmann; Thierry Ouedraogo; Boubacar Coulibaly; Ali Sié; Vanda Bartonova; Denis M Tebit; Hans-Georg Kräusslich
Journal:  Open AIDS J       Date:  2009-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.